Trial Profile
Phase 1, open label, single dose, parallel group study evaluating the pharmacokinetics, safety, and tolerability of amenamevir in healthy participants and participants with various degrees of renal impairment.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Nov 2017
Price :
$35
*
At a glance
- Drugs Amenamevir (Primary)
- Indications Herpes simplex virus infections; Herpes zoster
- Focus Pharmacokinetics
- 22 Nov 2017 New trial record
- 13 Nov 2017 Results published in the Advances in Therapy